Evidence map›Paper›PMID 41267796›Full record

Trial reportBioMed research international2025

Farjana Afrin, Mamtaz Mahal Neela, Arifin Islam, Md Rabiul Islam, Md Monir Hossain

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BioMed research international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. BioMed research international · 2025
    Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Farjana AfrinDepartment of Pharmacy, Jagannath University, Dhaka, Bangladesh, jagannathuniversity.org.
Mamtaz Mahal NeelaInstitute of Social Welfare and Research, University of Dhaka, Dhaka, Bangladesh, du.ac.bd.
Arifin IslamDepartment of Accounting & Information Systems (Statistics), Jagannath University, Dhaka, Bangladesh, jagannathuniversity.org.
Md Rabiul IslamSchool of Pharmacy, BRAC University, Dhaka, Bangladesh, bracu.ac.bd.ORCID https://orcid.org/0000-0003-2820-3144
Md Monir HossainDepartment of Pharmacy, Jagannath University, Dhaka, Bangladesh, jagannathuniversity.org.ORCID https://orcid.org/0009-0008-0874-0560

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Premenstrual syndrome (PMS) significantly affects women's quality of life, with fluctuations in estrogen levels implicated in symptom severity. Lower estrogen levels during the premenstrual phase may contribute to mood swings, anxiety, and fatigue. Methods: This was a randomized, double-blind, placebo-controlled clinical trial. Participants with moderate to severe PMS were identified using a Premenstrual Symptoms Screening Tool (PSST) questionnaire and randomly allocated to the placebo or treatment groups. Two capsules were consumed once a day for two menstrual cycles, and the severity of symptoms in the participants was monitored daily during the intervention, employing the daily record of severity of problems (DRSP). Results: At baseline, there were no significant differences ( Conclusion: The outcomes of this study indicated the favorable effects of

Indexed as

Nigella sativaPlant ExtractsPremenstrual SyndromeSeedsAdultDouble-Blind MethodEstradiolFemaleHumansQuality of LifeSeverity of Illness IndexYoung AdultEstradiolPlant Extractsdouble-blindedNigella sativaplacebo-controlled studypremenstrual syndromepremenstrual tensionrandomized

Identifiers

PMID41267796
PMCPMC12628082

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.